Global and United States Gastric Antisecretory Drug Market Insights, Forecast to 2031

Report ID: 1024984 | Published Date: Jan 2025 | No. of Page: 148 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Gastric Antisecretory Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Gastric Antisecretory Drug Market Size Growth Rate by Type
        1.2.2 H2-receptor Antagonists
        1.2.3 Gastric Proton Pump Inhibitors
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Gastric Antisecretory Drug Market Size Growth Rate by Application
        1.3.2 Dyspepsia
        1.3.3 Peptic Ulcer
        1.3.4 Gastroesophageal Reflux
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Gastric Antisecretory Drug Market Size, Estimates and Forecasts
        2.1.1 Global Gastric Antisecretory Drug Revenue 2016-2027
        2.1.2 Global Gastric Antisecretory Drug Sales 2016-2027
    2.2 Global Gastric Antisecretory Drug, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Gastric Antisecretory Drug Historical Market Size by Region (2016-2021)
        2.3.1 Global Gastric Antisecretory Drug Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Gastric Antisecretory Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Gastric Antisecretory Drug Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Gastric Antisecretory Drug Sales Forecast by Region (2022-2027)
        2.4.2 Global Gastric Antisecretory Drug Revenue Forecast by Region (2022-2027)

3 Global Gastric Antisecretory Drug Competitor Landscape by Players
    3.1 Global Top Gastric Antisecretory Drug Manufacturers by Sales
        3.1.1 Global Gastric Antisecretory Drug Sales by Manufacturer (2016-2021)
        3.1.2 Global Gastric Antisecretory Drug Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Gastric Antisecretory Drug Manufacturers by Revenue
        3.2.1 Key Gastric Antisecretory Drug Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Gastric Antisecretory Drug Revenue by Manufacturers (2016-2021)
        3.2.3 Global Gastric Antisecretory Drug Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Gastric Antisecretory Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Gastric Antisecretory Drug Revenue in 2020
        3.2.6 Global Gastric Antisecretory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Gastric Antisecretory Drug Price by Manufacturers
    3.4 Global Gastric Antisecretory Drug Manufacturing Base Distribution, Product Types
        3.4.1 Gastric Antisecretory Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Gastric Antisecretory Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Gastric Antisecretory Drug Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Gastric Antisecretory Drug Market Size by Type (2016-2021)
        4.1.1 Global Gastric Antisecretory Drug Sales by Type (2016-2021)
        4.1.2 Global Gastric Antisecretory Drug Revenue by Type (2016-2021)
        4.1.3 Gastric Antisecretory Drug Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Gastric Antisecretory Drug Market Size Forecast by Type (2022-2027)
        4.2.1 Global Gastric Antisecretory Drug Sales Forecast by Type (2022-2027)
        4.2.2 Global Gastric Antisecretory Drug Revenue Forecast by Type (2022-2027)
        4.2.3 Gastric Antisecretory Drug Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Gastric Antisecretory Drug Market Size by Application (2016-2021)
        5.1.1 Global Gastric Antisecretory Drug Sales by Application (2016-2021)
        5.1.2 Global Gastric Antisecretory Drug Revenue by Application (2016-2021)
        5.1.3 Gastric Antisecretory Drug Price by Application (2016-2021)
    5.2 Gastric Antisecretory Drug Market Size Forecast by Application (2022-2027)
        5.2.1 Global Gastric Antisecretory Drug Sales Forecast by Application (2022-2027)
        5.2.2 Global Gastric Antisecretory Drug Revenue Forecast by Application (2022-2027)
        5.2.3 Global Gastric Antisecretory Drug Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
    6.1 United States Gastric Antisecretory Drug Market Size YoY Growth 2016-2027
        6.1.1 United States Gastric Antisecretory Drug Sales YoY Growth 2016-2027
        6.1.2 United States Gastric Antisecretory Drug Revenue YoY Growth 2016-2027
        6.1.3 United States Gastric Antisecretory Drug Market Share in Global Market 2016-2027
    6.2 United States Gastric Antisecretory Drug Market Size by Players (International and Local Players)
        6.2.1 United States Top Gastric Antisecretory Drug Players by Sales (2016-2021)
        6.2.2 United States Top Gastric Antisecretory Drug Players by Revenue (2016-2021)
    6.3 United States Gastric Antisecretory Drug Historic Market Review by Type (2016-2021)
        6.3.1 United States Gastric Antisecretory Drug Sales Market Share by Type (2016-2021)
        6.3.2 United States Gastric Antisecretory Drug Revenue Market Share by Type (2016-2021)
        6.3.3 United States Gastric Antisecretory Drug Price by Type (2016-2021)
    6.4 United States Gastric Antisecretory Drug Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 United States Gastric Antisecretory Drug Sales Forecast by Type (2022-2027)
        6.4.2 United States Gastric Antisecretory Drug Revenue Forecast by Type (2022-2027)
        6.4.3 United States Gastric Antisecretory Drug Price Forecast by Type (2022-2027)
    6.5 United States Gastric Antisecretory Drug Historic Market Review by Application (2016-2021)
        6.5.1 United States Gastric Antisecretory Drug Sales Market Share by Application (2016-2021)
        6.5.2 United States Gastric Antisecretory Drug Revenue Market Share by Application (2016-2021)
        6.5.3 United States Gastric Antisecretory Drug Price by Application (2016-2021)
    6.6 United States Gastric Antisecretory Drug Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 United States Gastric Antisecretory Drug Sales Forecast by Application (2022-2027)
        6.6.2 United States Gastric Antisecretory Drug Revenue Forecast by Application (2022-2027)
        6.6.3 United States Gastric Antisecretory Drug Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Gastric Antisecretory Drug Market Size YoY Growth 2016-2027
    7.2 North America Gastric Antisecretory Drug Market Facts & Figures by Country
        7.2.1 North America Gastric Antisecretory Drug Sales by Country (2016-2021)
        7.2.2 North America Gastric Antisecretory Drug Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Gastric Antisecretory Drug Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Gastric Antisecretory Drug Market Facts & Figures by Region
        8.2.1 Asia Pacific Gastric Antisecretory Drug Sales by Region (2016-2021)
        8.2.2 Asia Pacific Gastric Antisecretory Drug Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe Gastric Antisecretory Drug Market Size YoY Growth 2016-2027
    9.2 Europe Gastric Antisecretory Drug Market Facts & Figures by Country
        9.2.1 Europe Gastric Antisecretory Drug Sales by Country (2016-2021)
        9.2.2 Europe Gastric Antisecretory Drug Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Gastric Antisecretory Drug Market Size YoY Growth 2016-2027
    10.2 Latin America Gastric Antisecretory Drug Market Facts & Figures by Country
        10.2.1 Latin America Gastric Antisecretory Drug Sales by Country (2016-2021)
        10.2.2 Latin America Gastric Antisecretory Drug Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Gastric Antisecretory Drug Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Gastric Antisecretory Drug Market Facts & Figures by Country
        11.2.1 Middle East and Africa Gastric Antisecretory Drug Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Gastric Antisecretory Drug Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 Bayer
        12.1.1 Bayer Corporation Information
        12.1.2 Bayer Description and Business Overview
        12.1.3 Bayer Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Bayer Gastric Antisecretory Drug Products Offered
        12.1.5 Bayer Recent Development
    12.2 Cadila Pharmaceuticals
        12.2.1 Cadila Pharmaceuticals Corporation Information
        12.2.2 Cadila Pharmaceuticals Description and Business Overview
        12.2.3 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Cadila Pharmaceuticals Gastric Antisecretory Drug Products Offered
        12.2.5 Cadila Pharmaceuticals Recent Development
    12.3 AstraZeneca
        12.3.1 AstraZeneca Corporation Information
        12.3.2 AstraZeneca Description and Business Overview
        12.3.3 AstraZeneca Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 AstraZeneca Gastric Antisecretory Drug Products Offered
        12.3.5 AstraZeneca Recent Development
    12.4 Jiangsu Aosaikang
        12.4.1 Jiangsu Aosaikang Corporation Information
        12.4.2 Jiangsu Aosaikang Description and Business Overview
        12.4.3 Jiangsu Aosaikang Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Jiangsu Aosaikang Gastric Antisecretory Drug Products Offered
        12.4.5 Jiangsu Aosaikang Recent Development
    12.5 Eisai
        12.5.1 Eisai Corporation Information
        12.5.2 Eisai Description and Business Overview
        12.5.3 Eisai Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Eisai Gastric Antisecretory Drug Products Offered
        12.5.5 Eisai Recent Development
    12.6 Pfizer
        12.6.1 Pfizer Corporation Information
        12.6.2 Pfizer Description and Business Overview
        12.6.3 Pfizer Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Pfizer Gastric Antisecretory Drug Products Offered
        12.6.5 Pfizer Recent Development
    12.7 Altana Pharma
        12.7.1 Altana Pharma Corporation Information
        12.7.2 Altana Pharma Description and Business Overview
        12.7.3 Altana Pharma Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Altana Pharma Gastric Antisecretory Drug Products Offered
        12.7.5 Altana Pharma Recent Development
    12.8 Takeda
        12.8.1 Takeda Corporation Information
        12.8.2 Takeda Description and Business Overview
        12.8.3 Takeda Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Takeda Gastric Antisecretory Drug Products Offered
        12.8.5 Takeda Recent Development
    12.9 NCPC
        12.9.1 NCPC Corporation Information
        12.9.2 NCPC Description and Business Overview
        12.9.3 NCPC Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 NCPC Gastric Antisecretory Drug Products Offered
        12.9.5 NCPC Recent Development
    12.10 Luoxin
        12.10.1 Luoxin Corporation Information
        12.10.2 Luoxin Description and Business Overview
        12.10.3 Luoxin Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Luoxin Gastric Antisecretory Drug Products Offered
        12.10.5 Luoxin Recent Development
    12.11 Bayer
        12.11.1 Bayer Corporation Information
        12.11.2 Bayer Description and Business Overview
        12.11.3 Bayer Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Bayer Gastric Antisecretory Drug Products Offered
        12.11.5 Bayer Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Gastric Antisecretory Drug Industry Trends
    13.2 Gastric Antisecretory Drug Market Drivers
    13.3 Gastric Antisecretory Drug Market Challenges
    13.4 Gastric Antisecretory Drug Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Gastric Antisecretory Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Gastric Antisecretory Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of H2-receptor Antagonists
    Table 3. Major Manufacturers of Gastric Proton Pump Inhibitors
    Table 4. Major Manufacturers of Others
    Table 5. Global Gastric Antisecretory Drug Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 6. Global Gastric Antisecretory Drug Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 7. Global Gastric Antisecretory Drug Sales by Regions (2016-2021) & (K Units)
    Table 8. Global Gastric Antisecretory Drug Sales Market Share by Regions (2016-2021)
    Table 9. Global Gastric Antisecretory Drug Revenue by Regions (2016-2021) & (US$ Million)
    Table 10. Global Gastric Antisecretory Drug Sales Forecast by Region (2022-2027) & (K Units)
    Table 11. Global Gastric Antisecretory Drug Sales Market Share Forecast by Region (2022-2027)
    Table 12. Global Gastric Antisecretory Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 13. Global Gastric Antisecretory Drug Revenue Market Share Forecast by Region (2022-2027)
    Table 14. Global Gastric Antisecretory Drug Sales by Manufacturers (2016-2021) (K Units)
    Table 15. Global Gastric Antisecretory Drug Sales Share by Manufacturers (2016-2021)
    Table 16. Ranking of Global Top Gastric Antisecretory Drug Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Gastric Antisecretory Drug Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 18. Gastric Antisecretory Drug Revenue Share by Manufacturers (2016-2021)
    Table 19. Global Gastric Antisecretory Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 20. Global Gastric Antisecretory Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Antisecretory Drug as of 2020)
    Table 21. Key Manufacturers Gastric Antisecretory Drug Price (2016-2021) (US$/Unit)
    Table 22. Gastric Antisecretory Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Gastric Antisecretory Drug Product Type
    Table 24. Date of International Manufacturers Enter into Gastric Antisecretory Drug Market
    Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 26. Global Gastric Antisecretory Drug Sales by Type (2016-2021) (K Units)
    Table 27. Global Gastric Antisecretory Drug Sales Share by Type (2016-2021)
    Table 28. Global Gastric Antisecretory Drug Revenue by Type (2016-2021) (US$ Million)
    Table 29. Global Gastric Antisecretory Drug Revenue Share by Type (2016-2021)
    Table 30. Gastric Antisecretory Drug Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 31. Global Gastric Antisecretory Drug Sales Forecast by Type (2022-2027) & (K Units)
    Table 32. Global Gastric Antisecretory Drug Sales Market Share Forecast by Type (2022-2027)
    Table 33. Global Gastric Antisecretory Drug Revenue Forecast V (2022-2027) & (US$ Million)
    Table 34. Global Gastric Antisecretory Drug Revenue Market Share Forecast by Type (2022-2027)
    Table 35. Global Gastric Antisecretory Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 36. Global Gastric Antisecretory Drug Sales by Application (2016-2021) (K Units)
    Table 37. Global Gastric Antisecretory Drug Sales Share by Application (2016-2021)
    Table 38. Global Gastric Antisecretory Drug Revenue by Application (2016-2021) (US$ Million)
    Table 39. Global Gastric Antisecretory Drug Revenue Share by Application (2016-2021)
    Table 40. Gastric Antisecretory Drug Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 41. Global Gastric Antisecretory Drug Sales Forecast by Application (2022-2027) & (K Units)
    Table 42. Global Gastric Antisecretory Drug Sales Market Share Forecast by Application (2022-2027)
    Table 43. Global Gastric Antisecretory Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 44. Global Gastric Antisecretory Drug Revenue Market Share Forecast by Application (2022-2027)
    Table 45. Global Gastric Antisecretory Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 46. United States Gastric Antisecretory Drug Sales (K Units) of Key Companies (2016-2021)
    Table 47. United States Gastric Antisecretory Drug Sales Share by Company (2016-2021)
    Table 48. United States Gastric Antisecretory Drug Revenue (US$ Million) by Company (2016-2021)
    Table 49. United States Gastric Antisecretory Drug Revenue Share by Company (2016-2021)
    Table 50. United States Gastric Antisecretory Drug Sales (K Units) by Type (2016-2021)
    Table 51. United States Gastric Antisecretory Drug Sales Share by Type (2016-2021)
    Table 52. United States Gastric Antisecretory Drug Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 53. United States Gastric Antisecretory Drug Price (US$/Unit) by Type (2016-2021)
    Table 54. United States Gastric Antisecretory Drug Sales (K Units) by Type (2022-2027)
    Table 55. United States Gastric Antisecretory Drug Sales Share by Type (2022-2027)
    Table 56. United States Gastric Antisecretory Drug Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 57. United States Gastric Antisecretory Drug Revenue Share by Type (2022-2027)
    Table 58. United States Gastric Antisecretory Drug Price (US$/Unit) by Type (2022-2027)
    Table 59. United States Gastric Antisecretory Drug Sales (K Units) by Application (2016-2021)
    Table 60. United States Gastric Antisecretory Drug Sales Share by Application (2016-2021)
    Table 61. United States Gastric Antisecretory Drug Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 62. United States Gastric Antisecretory Drug Price (US$/Unit) by Application (2016-2021)
    Table 63. United States Gastric Antisecretory Drug Sales (K Units) by Application (2022-2027)
    Table 64. United States Gastric Antisecretory Drug Sales Share by Application (2022-2027)
    Table 65. United States Gastric Antisecretory Drug Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 66. United States Gastric Antisecretory Drug Revenue Share by Application (2022-2027)
    Table 67. United States Gastric Antisecretory Drug Price (US$/Unit) by Application (2022-2027)
    Table 68. North America Gastric Antisecretory Drug Sales by Country (2016-2021) & (K Units)
    Table 69. North America Gastric Antisecretory Drug Sales Market Share by Country (2016-2021)
    Table 70. North America Gastric Antisecretory Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 71. North America Gastric Antisecretory Drug Revenue Market Share by Country (2016-2021)
    Table 72. Asia Pacific Gastric Antisecretory Drug Sales by Region (2016-2021) & (K Units)
    Table 73. Asia Pacific Gastric Antisecretory Drug Sales Market Share by Region (2016-2021)
    Table 74. Asia Pacific Gastric Antisecretory Drug Revenue by Region (2016-2021) & (US$ Million)
    Table 75. Asia Pacific Gastric Antisecretory Drug Revenue Market Share by Region (2016-2021)
    Table 76. Europe Gastric Antisecretory Drug Sales by Country (2016-2021) & (K Units)
    Table 77. Europe Gastric Antisecretory Drug Sales Market Share by Country (2016-2021)
    Table 78. Europe Gastric Antisecretory Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 79. Europe Gastric Antisecretory Drug Revenue Market Share by Country (2016-2021)
    Table 80. Latin America Gastric Antisecretory Drug Sales by Country (2016-2021) & (K Units)
    Table 81. Latin America Gastric Antisecretory Drug Sales Market Share by Country (2016-2021)
    Table 82. Latin Americaa Gastric Antisecretory Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 83. Latin America Gastric Antisecretory Drug Revenue Market Share by Country (2016-2021)
    Table 84. Middle East and Africa Gastric Antisecretory Drug Sales by Country (2016-2021) & (K Units)
    Table 85. Middle East and Africa Gastric Antisecretory Drug Sales Market Share by Country (2016-2021)
    Table 86. Middle East and Africa Gastric Antisecretory Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 87. Middle East and Africa Gastric Antisecretory Drug Revenue Market Share by Country (2016-2021)
    Table 88. Bayer Corporation Information
    Table 89. Bayer Description and Business Overview
    Table 90. Bayer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 91. Bayer Gastric Antisecretory Drug Product
    Table 92. Bayer Recent Development
    Table 93. Cadila Pharmaceuticals Corporation Information
    Table 94. Cadila Pharmaceuticals Description and Business Overview
    Table 95. Cadila Pharmaceuticals Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 96. Cadila Pharmaceuticals Product
    Table 97. Cadila Pharmaceuticals Recent Development
    Table 98. AstraZeneca Corporation Information
    Table 99. AstraZeneca Description and Business Overview
    Table 100. AstraZeneca Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 101. AstraZeneca Product
    Table 102. AstraZeneca Recent Development
    Table 103. Jiangsu Aosaikang Corporation Information
    Table 104. Jiangsu Aosaikang Description and Business Overview
    Table 105. Jiangsu Aosaikang Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 106. Jiangsu Aosaikang Product
    Table 107. Jiangsu Aosaikang Recent Development
    Table 108. Eisai Corporation Information
    Table 109. Eisai Description and Business Overview
    Table 110. Eisai Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 111. Eisai Product
    Table 112. Eisai Recent Development
    Table 113. Pfizer Corporation Information
    Table 114. Pfizer Description and Business Overview
    Table 115. Pfizer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 116. Pfizer Product
    Table 117. Pfizer Recent Development
    Table 118. Altana Pharma Corporation Information
    Table 119. Altana Pharma Description and Business Overview
    Table 120. Altana Pharma Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 121. Altana Pharma Product
    Table 122. Altana Pharma Recent Development
    Table 123. Takeda Corporation Information
    Table 124. Takeda Description and Business Overview
    Table 125. Takeda Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 126. Takeda Product
    Table 127. Takeda Recent Development
    Table 128. NCPC Corporation Information
    Table 129. NCPC Description and Business Overview
    Table 130. NCPC Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 131. NCPC Product
    Table 132. NCPC Recent Development
    Table 133. Luoxin Corporation Information
    Table 134. Luoxin Description and Business Overview
    Table 135. Luoxin Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 136. Luoxin Product
    Table 137. Luoxin Recent Development
    Table 138. Gastric Antisecretory Drug Market Trends
    Table 139. Gastric Antisecretory Drug Market Drivers
    Table 140. Gastric Antisecretory Drug Market Challenges
    Table 141. Gastric Antisecretory Drug Market Restraints
    Table 142. Gastric Antisecretory Drug Customers List
    Table 143. Gastric Antisecretory Drug Distributors List
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastric Antisecretory Drug Product Picture
    Figure 2. Global Gastric Antisecretory Drug Sales Market Share by Type in 2020 & 2027
    Figure 3. H2-receptor Antagonists Product Picture
    Figure 4. Gastric Proton Pump Inhibitors Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Gastric Antisecretory Drug Sales Market Share by Application in 2020 & 2027
    Figure 7. Dyspepsia
    Figure 8. Peptic Ulcer
    Figure 9. Gastroesophageal Reflux
    Figure 10. Others
    Figure 11. Gastric Antisecretory Drug Report Years Considered
    Figure 12. Global Gastric Antisecretory Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Gastric Antisecretory Drug Market Size 2016-2027 (US$ Million)
    Figure 14. Global Gastric Antisecretory Drug Sales 2016-2027 (K Units)
    Figure 15. Global Gastric Antisecretory Drug Market Size Market Share by Region: 2021 Versus 2027
    Figure 16. Global Gastric Antisecretory Drug Sales Market Share by Region (2016-2021)
    Figure 17. Global Gastric Antisecretory Drug Sales Market Share by Region in 2020
    Figure 18. Global Gastric Antisecretory Drug Revenue Market Share by Region (2016-2021)
    Figure 19. Global Gastric Antisecretory Drug Revenue Market Share by Region in 2020
    Figure 20. Global Gastric Antisecretory Drug Sales Share by Manufacturer in 2020
    Figure 21. The Top 10 and 5 Players Market Share by Gastric Antisecretory Drug Revenue in 2020
    Figure 22. Gastric Antisecretory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 23. Global Gastric Antisecretory Drug Sales Market Share by Type (2016-2021)
    Figure 24. Global Gastric Antisecretory Drug Sales Market Share by Type in 2020
    Figure 25. Global Gastric Antisecretory Drug Revenue Market Share by Type (2016-2021)
    Figure 26. Global Gastric Antisecretory Drug Revenue Market Share by Type in 2020
    Figure 27. Global Gastric Antisecretory Drug Sales Market Share by Application (2016-2021)
    Figure 28. Global Gastric Antisecretory Drug Sales Market Share by Application in 2020
    Figure 29. Global Gastric Antisecretory Drug Revenue Market Share by Application (2016-2021)
    Figure 30. Global Gastric Antisecretory Drug Revenue Market Share by Application in 2020
    Figure 31. United States Gastric Antisecretory Drug Sales Growth Rate 2016-2027 (K Units)
    Figure 32. United States Gastric Antisecretory Drug Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 33. United States Gastric Antisecretory Drug Market Share in Global Market 2016-2027
    Figure 34. United States 5 and 10 Largest Gastric Antisecretory Drug Players Market Share by Revenue in Gastric Antisecretory Drug in 2020
    Figure 35. United States Gastric Antisecretory Drug Revenue Share by Type (2016-2021)
    Figure 36. United States Gastric Antisecretory Drug Revenue Growth Rate by Type in 2016 & 2020
    Figure 37. United States Gastric Antisecretory Drug Revenue Share by Application (2016-2021)
    Figure 38. United States Gastric Antisecretory Drug Revenue Growth Rate by Application in 2016 & 2020
    Figure 39. North America Gastric Antisecretory Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 40. North America Gastric Antisecretory Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 41. North America Gastric Antisecretory Drug Sales Market Share by Country in 2020
    Figure 42. North America Gastric Antisecretory Drug Revenue Market Share by Country in 2020
    Figure 43. U.S. Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 44. U.S. Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Canada Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 46. Canada Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Europe Gastric Antisecretory Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 48. Europe Gastric Antisecretory Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 49. Europe Gastric Antisecretory Drug Sales Market Share by Country in 2020
    Figure 50. Europe Gastric Antisecretory Drug Revenue Market Share by Country in 2020
    Figure 51. Germany Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 52. Germany Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. France Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 54. France Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. U.K. Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 56. U.K. Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Italy Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Italy Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Russia Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 60. Russia Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 61. Asia Pacific Gastric Antisecretory Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 62. Asia Pacific Gastric Antisecretory Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 63. Asia Pacific Gastric Antisecretory Drug Sales Market Share by Region in 2020
    Figure 64. Asia Pacific Gastric Antisecretory Drug Revenue Market Share by Region in 2020
    Figure 65. China Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 66. China Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. Japan Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 68. Japan Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. South Korea Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 70. South Korea Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. India Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 72. India Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Australia Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 74. Australia Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Taiwan Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 76. Taiwan Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Indonesia Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Indonesia Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Thailand Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Thailand Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Malaysia Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 82. Malaysia Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Philippines Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 84. Philippines Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 85. Vietnam Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 86. Vietnam Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 87. Latin America Gastric Antisecretory Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 88. Latin America Gastric Antisecretory Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 89. Latin America Gastric Antisecretory Drug Sales Market Share by Country in 2020
    Figure 90. Latin America Gastric Antisecretory Drug Revenue Market Share by Country in 2020
    Figure 91. Mexico Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 92. Mexico Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Brazil Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 94. Brazil Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 95. Argentina Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 96. Argentina Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 97. Middle East and Africa Gastric Antisecretory Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 98. Middle East and Africa Gastric Antisecretory Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 99. Middle East and Africa Gastric Antisecretory Drug Sales Market Share by Country in 2020
    Figure 100. Middle East and Africa Gastric Antisecretory Drug Revenue Market Share by Country in 2020
    Figure 101. Turkey Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 102. Turkey Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. Saudi Arabia Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 104. Saudi Arabia Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 105. UAE Gastric Antisecretory Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 106. UAE Gastric Antisecretory Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 107. Gastric Antisecretory Drug Value Chain
    Figure 108. Channels of Distribution
    Figure 109. Distributors Profiles
    Figure 110. Bottom-up and Top-down Approaches for This Report
    Figure 111. Data Triangulation
    Figure 112. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
Frequently Asked Questions
Gastric Antisecretory Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastric Antisecretory Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastric Antisecretory Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Exam Gown

Exam Gown market is segmented by region (country), players, by Type, and by Application. Players, ... Read More